Following A -1.71% Weekly Decline, Is It Still A Buy For Azenta Inc (NASDAQ: AZTA)?
Azenta Inc (NASDAQ:AZTA)’s traded shares stood at 0.87 million during the last session, with the company’s beta value hitting 1.64. At the close of trading,
Azenta Inc (NASDAQ:AZTA)’s traded shares stood at 0.87 million during the last session, with the company’s beta value hitting 1.64. At the close of trading,
Aldeyra Therapeutics Inc (NASDAQ:ALDX)’s traded shares stood at 0.7 million during the last session, with the company’s beta value hitting 0.71. At the close of
Trupanion Inc (NASDAQ:TRUP)’s traded shares stood at 0.39 million during the last session, with the company’s beta value hitting 1.78. At the close of trading,
OneMain Holdings Inc (NYSE:OMF)’s traded shares stood at 0.83 million during the last session, with the company’s beta value hitting 1.28. At the close of
Corvus Pharmaceuticals Inc (NASDAQ:CRVS)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 0.54. At the close of
Ichor Holdings Ltd (NASDAQ:ICHR)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 1.81. At the close of
Akoya Biosciences Inc (NASDAQ:AKYA)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 1.37. At the close of
Olaplex Holdings Inc (NASDAQ:OLPX)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 2.33. At the close of
Enovis Corp (NYSE:ENOV)’s traded shares stood at 0.69 million during the last session, with the company’s beta value hitting 1.54. At the close of trading,
Ecolab, Inc (NYSE:ECL)’s traded shares stood at 0.8 million during the last session, with the company’s beta value hitting 1.04. At the close of trading,
© 2024, Powered by Smart TechOne